DUBLIN--(BUSINESS WIRE)--The "Global Insulin Delivery Devices Market (By Type - Insulin Pen, Insulin Vial & Syringes and Insulin Pumps; By Region - Europe, North America & Asia Pacific) Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global insulin delivery devices market.
Insulin delivery devices have evolved in a big way from conventional metal syringes to intelligent insulin pens and implantable Continuous Glucose Monitoring (CGM) system for glycemic control in people with diabetes. In the year 2018, FDA approved Senseonics' Eversense continuous glucose monitoring (CGM) system, the first implantable CGM in the United States.
Market outlook for insulin delivery devices market overall as well as across various sub-segments has been provided for the period 2018-2024. Regional analysis is done across major markets in North America, Europe and the Asia Pacific.
Market Dynamics
Industry Trends & Developments
- Closed-Looped Insulin Delivery/Artificial Pancreas System
- Implantable Continuous Glucose Monitoring (CGM) System
- Advent of Intelligent Insulin Pens
- Next-Generation Insulin Management System Platform
Growth Drivers
- Increasing Incidences of Diabetes
- Rise in Geriatric Population
- Growing Obese Population
- Propagation of Diabetes Management Awareness
- Government Impetus
Challenges
- High Cost of Insulin Pumps
- Insurance Coverage issue
- Regulatory Pressure
- Technological Issue
Scope of the Report
Market Segments
- Vials & Syringes
- Insulin Pens
- Insulin Pumps
Key Vendors
- Novo Nordisk
- Sanofi Aventis
- Eli Lilly and Company
- Merck & Co.
Products Mentioned
- Insulin
- Insulin delivery devices
- Insulin pumps
- Insulin syringes
- Insulin pen
- Diabetes
For more information about this report visit https://www.researchandmarkets.com/research/28lmv9/global_insulin?w=4
